Niebora J, Data K, Domagala D, Jozkowiak M, Barrett S, Norizadeh Abbariki T
Cells. 2024; 13(21.
PMID: 39513904
PMC: 11544849.
DOI: 10.3390/cells13211797.
Salvi A, Li W, Dipali S, Cologna S, Pavone M, Duncan F
Heliyon. 2024; 10(6):e27336.
PMID: 38501015
PMC: 10945186.
DOI: 10.1016/j.heliyon.2024.e27336.
Park C, Lin P, Zhou S, Barakat R, Bashir S, Choi J
Cell Rep. 2020; 31(2):107496.
PMID: 32294429
PMC: 7211423.
DOI: 10.1016/j.celrep.2020.03.060.
Tudrej P, Kujawa K, Cortez A, Lisowska K
Diagnostics (Basel). 2019; 9(3).
PMID: 31540126
PMC: 6787695.
DOI: 10.3390/diagnostics9030120.
Zink K, Dean M, Burdette J, Sanchez L
J Vis Exp. 2019; (146).
PMID: 31009015
PMC: 6638549.
DOI: 10.3791/59490.
BNC2 is a putative tumor suppressor gene in high-grade serous ovarian carcinoma and impacts cell survival after oxidative stress.
Cesaratto L, Grisard E, Coan M, Zandona L, De Mattia E, Poletto E
Cell Death Dis. 2016; 7(9):e2374.
PMID: 27899818
PMC: 5059877.
DOI: 10.1038/cddis.2016.278.
Galectin-3 supports stemness in ovarian cancer stem cells by activation of the Notch1 intracellular domain.
Kang H, Kim D, Kim S, Cho Y, Jung J, Jang W
Oncotarget. 2016; 7(42):68229-68241.
PMID: 27626163
PMC: 5356551.
DOI: 10.18632/oncotarget.11920.
Advantages of the avian model for human ovarian cancer.
Bernardo A, Thorsteinsdottir S, Mummery C
Mol Clin Oncol. 2016; 3(6):1191-1198.
PMID: 26807219
PMC: 4665342.
DOI: 10.3892/mco.2015.619.
Spontaneous Transformation of Murine Oviductal Epithelial Cells: A Model System to Investigate the Onset of Fallopian-Derived Tumors.
Endsley M, Moyle-Heyrman G, Karthikeyan S, Lantvit D, Davis D, Wei J
Front Oncol. 2015; 5:154.
PMID: 26236688
PMC: 4505108.
DOI: 10.3389/fonc.2015.00154.
Dysregulated estrogen receptor signaling in the hypothalamic-pituitary-ovarian axis leads to ovarian epithelial tumorigenesis in mice.
Laws M, Kannan A, Pawar S, Haschek W, Bagchi M, Bagchi I
PLoS Genet. 2014; 10(3):e1004230.
PMID: 24603706
PMC: 3945209.
DOI: 10.1371/journal.pgen.1004230.
Recreating the female reproductive tract in vitro using iPSC technology in a linked microfluidics environment.
Laronda M, Burdette J, Kim J, Woodruff T
Stem Cell Res Ther. 2014; 4 Suppl 1:S13.
PMID: 24565375
PMC: 4029530.
DOI: 10.1186/scrt374.
Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.
Jones P, Drapkin R
Front Oncol. 2013; 3:217.
PMID: 23986883
PMC: 3752910.
DOI: 10.3389/fonc.2013.00217.
Gonadotropins activate oncogenic pathways to enhance proliferation in normal mouse ovarian surface epithelium.
Hilliard T, Modi D, Burdette J
Int J Mol Sci. 2013; 14(3):4762-82.
PMID: 23449028
PMC: 3634497.
DOI: 10.3390/ijms14034762.
Immunohistochemical evaluation of cell proliferation and apoptosis markers in ovarian surface epithelial cells of cladribine-treated rats.
Jedrych M, Wawryk-Gawda E, Jodlowska-Jedrych B, Chylinska-Wrzos P, Jasinski L
Protoplasma. 2013; 250(5):1025-34.
PMID: 23344798
PMC: 3788177.
DOI: 10.1007/s00709-012-0461-z.
Technical challenges and limitations of current mouse models of ovarian cancer.
Garson K, Gamwell L, Pitre E, Vanderhyden B
J Ovarian Res. 2012; 5(1):39.
PMID: 23190474
PMC: 3537528.
DOI: 10.1186/1757-2215-5-39.
Ovarian cancer stem cells: elusive targets for chemotherapy.
Guddati A
Med Oncol. 2012; 29(5):3400-8.
PMID: 22638913
DOI: 10.1007/s12032-012-0252-6.
Minireview: animal models and mechanisms of ovarian cancer development.
Mullany L, Richards J
Endocrinology. 2012; 153(4):1585-92.
PMID: 22396450
PMC: 3320247.
DOI: 10.1210/en.2011-2121.